BPC-157 + TB500
BPC-157 + TB500
This blend combines two of the most extensively researched tissue repair peptides: BPC-157 and TB-500. Research demonstrates BPC-157 supports healing of muscle, tendon, ligament and joint tissue through growth factor receptor upregulation and angiogenesis promotion. TB-500 — the active fragment of Thymosin Beta-4 — has shown wound healing acceleration in human Phase I/II clinical trials, with studies demonstrating enhanced cell migration, reduced inflammation and improved connective tissue repair.
Supplied as research-grade lyophilised blend. Requires reconstitution with bacteriostatic water prior to use. For research purposes only.
Research Stack Builder
Build Your Research Stack
Curated combinations based on what researchers actually stack — backed by published data, priced to save.
Stack with BPC-157 + TB500
Why researchers stack these
- 01Structural repair from three distinct angles
- 02Cellular energy to sustain active recovery
- 03Most combined recovery stack on Peptide Pal
Full research context
BPC-157 and TB-500 address musculoskeletal repair through complementary mechanisms — nitric oxide and angiogenesis vs actin-sequestering and satellite cell activation. GHK-Cu extends this into the extracellular matrix through collagen synthesis stimulation and broad gene modulation. NAD+ and MOTS-c provide the cellular energy substrate: tissue regeneration is metabolically costly, and researchers consistently report better outcomes when ATP production is supported alongside the repair signalling cascade.
Recovery & Repair Protocol
The most studied peptide combination for tissue repair, injury recovery & musculoskeletal healing
Why researchers stack these
- 01Non-competing structural repair pathways
- 02BPC-157 angiogenesis + TB-500 satellite cell activation
- 03GHK-Cu adds the extracellular matrix layer both lack
Full research context
BPC-157 and TB-500 are the two most frequently co-researched repair peptides in published literature, acting through complementary mechanisms — BPC-157 via nitric oxide pathways and angiogenesis, TB-500 via actin-sequestering and satellite cell activation. GHK-Cu rounds out the stack by supporting collagen synthesis and the extracellular matrix that both compounds do not directly address, while reducing the oxidative load that slows tissue recovery.
Metabolic & Body Recomposition
Most popular Peptide Pal stack — two non-competing fat loss axes with skin integrity support
Why researchers stack these
- 01GLP-1 triple agonism + GH axis — two distinct fat loss pathways
- 02Skin integrity preserved throughout recomposition
- 03Most purchased together on Peptide Pal
Full research context
Retatrutide and Tesamorelin address body composition through two non-competing mechanisms. Retatrutide's triple receptor agonism drives broad metabolic improvement and appetite regulation; Tesamorelin is FDA-approved for visceral adipose reduction through the growth hormone axis — a distinct mechanism. GHK-Cu supports skin integrity during recomposition; rapid fat loss without collagen support produces visible skin laxity that is far harder to address after the fact.
Cognitive Performance Stack
Neuropeptides studied for synergistic cognitive enhancement, focus & stress resilience — no sedation
Why researchers stack these
- 01BDNF stimulation balanced by GABA modulation
- 02Focus without anxiety — three non-competing pathways
- 03NAD+ fuels the neuronal energy demand
Full research context
Semax and Selank are registered pharmaceuticals with distinct mechanisms. Semax drives BDNF upregulation and cortical processing speed; Selank reduces the stress-induced cognitive interference that can blunt that effect, without sedation or dependency. NAD+ provides the cellular energy substrate that enhanced neuronal activity demands — researchers consistently report that this combination delivers balanced cognitive performance that neither compound achieves alone.
Skin & Glow Protocol
Collagen synthesis, antioxidant protection & melanin research in one comprehensive skin stack
Why researchers stack these
- 01Collagen, antioxidant & pigmentation — three skin pillars
- 02Tyrosinase inhibition counterbalances MC1R agonism for pathway research
- 03Structural integrity maintained alongside brightening
Full research context
GHK-Cu stimulates collagen synthesis and modulates over 4,000 genes involved in skin repair and inflammatory control — addressing the structural layer. Glutathione reduces oxidative stress and inhibits tyrosinase, producing measurable skin brightening with 30–35% tissue GSH increases confirmed in human RCTs. MT2 drives eumelanin synthesis via MC1R agonism, and researchers frequently combine it with Glutathione to study the interplay between melanocortin-driven pigmentation and tyrosinase inhibition simultaneously. Together these three represent the most comprehensive skin research protocol available.
Cellular Longevity Protocol
Three compounds that decline together with age — combined restoration for mitochondrial & cellular health
Why researchers stack these
- 01All three decline together with age — parallel restoration
- 02Mitochondrial energy, AMPK signalling & antioxidant protection
- 03Most complete cellular longevity protocol available
Full research context
NAD+, MOTS-c, and glutathione all decline measurably with age through parallel but distinct pathways. NAD+ restores sirtuin and PARP function essential for mitochondrial biogenesis and DNA repair — declining up to 50% by age 60. MOTS-c is the mitochondria-derived peptide that activates AMPK signalling and declines alongside NAD+; their combined restoration is the most researched longevity intervention. Glutathione provides the antioxidant protection that prevents cellular damage during the heightened metabolic activity that NAD+ and MOTS-c restoration drives — completing what researchers describe as the foundational cellular longevity triad.
Research & Studies
Peer-reviewed research supporting BPC-157 + TB500
BPC-157: Stable Gastric Pentadecapeptide Demonstrates Systemic Organ Healing and Cytoprotection
BPC-157, a 15-amino acid peptide derived from a protective protein in gastric juice, has demonstrated potent cytoprotective, angiogenic, and tissue-healing activity across multiple organ systems in extensive research. Key findings include accelerated healing of muscle, tendon, ligament, bone, cornea, and intestinal tissue, alongside modulation of nitric oxide pathways, growth factor receptor expression, and inflammatory cytokine profiles. BPC-157 is notable for its exceptional safety profile and lack of adverse effects across all doses tested, supporting its investigation as a broad-spectrum tissue repair research compound.
BPC-157 Accelerates Tendon Healing and Outperforms Growth Factor Treatment in Controlled Research
Chang et al. demonstrated that BPC-157 administration significantly accelerated Achilles tendon healing compared to both control and growth factor treatment groups, with tendon cells showing enhanced migration, survival, and organisation. BPC-157 upregulated tendon growth factor receptor expression and promoted formation of well-organised collagen fibres with improved biomechanical properties. The compound outperformed direct growth factor application, suggesting a superior mechanism of action relevant to musculoskeletal recovery research.
Thymosin β4 Demonstrates Cardioprotective and Wound Healing Benefits in Human Phase I/II Trials
Thymosin β4 (Tβ4), the parent compound of TB-500, progressed into human Phase I and Phase II clinical trials demonstrating both cardiac and dermal healing applications. In patients with ischaemic heart disease, Tβ4 promoted cardiac repair and regeneration. Separately, controlled clinical trials in patients with non-healing venous stasis ulcers showed Tβ4 significantly accelerated wound closure versus placebo, with full wound closure rates substantially higher in the treatment group — providing direct human evidence of clinically meaningful tissue repair promotion.
TB-500 / Thymosin β4 Fragment: Muscle Repair and Anti-Inflammatory Activity in Tissue Research
Philp et al. characterised the actin-sequestering domain of Thymosin β4 — the fragment corresponding to TB-500 — as the primary mediator of cell migration, proliferation, and differentiation in muscle and connective tissue repair. The research demonstrated that this fragment alone was sufficient to drive the wound healing response, promoting satellite cell activation, reducing inflammatory infiltration, and accelerating the restoration of functional muscle architecture. These findings provided the mechanistic foundation for TB-500 as a targeted fragment of the parent Tβ4 molecule with focused tissue repair activity.